You can read more here: To view or add a comment, sign in ASTCT submitted comments to CMS on the CY 2026 OPPS proposed rule, advocating for improved reimbursement policies for transplant and cellular therapies
ADC Patent Strategy: Protecting the Linker, Not Just the Antibody Companies operating in the ADC space file patents on multiple stacked layers: the antibody component (often already patented), the linker chemistry, the payload structure, the drug-to-antibody ratio (DAR), the conjugation methodology, and the specific tumor antigen targeted
Efficacy Data: The trials demonstrated that a 2mg daily dose of Tesamorelin significantly reduced visceral adipose tissue (by approximately 15-18%) over a 26-week period
Nawrocki ensures the plan evolves to meet your needs and maintains your progress toward your goals
Modalits de retour Les frais de retour sont la charge du client
If youre a research buyer: you may see longer lead times and more volatility for GLP1-related materials that previously moved with minimal friction